Article
Exploring biomarkers in head and neck cancer.
Cancer - 15 Aug 2012
Langer Corey J
Abstract excerpt
Personalized medicine based on predictive markers linked to drug response, it is hoped, will lead to improvements in outcomes and avoidance of unnecessary treatment in squamous cell carcinoma of the head and neck (SCCHN). Recent research has shown that expression of ERCC1 may predict resistance to treatment with platinum agents. Future testing for this marker may help select the optimal type of chemotherapy....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
